How Supply Chain Gaps in Healthcare Delay Patient Treatment
June 30, 2026 by Medigroup
You confirmed the procedure. You told your patient everything was set. Then the call comes: the propofol vial your team ordered two weeks ago is on backorder nationwide, the surgical kit your vendor promised arrived incomplete, and you need to reschedule a procedure that was already rescheduled once before.
This is not a rare edge case anymore. Healthcare supply chain disruption has become a defining operational pressure for physician offices, ambulatory surgery centers (ASCs), and non-acute facilities across the country. Unlike large hospital systems, these facilities have no dedicated procurement department, no multi-vendor enterprise contracts, and no buffer stock room. When a shortage hits, it hits the schedule directly.
This post names exactly where those gaps come from, what drugs and devices face active shortages right now, and the specific actions your facility can take today to protect your patients and your schedule.
The Real Causes of Supply Chain Disruption Hitting Facilities in 2026
Healthcare supply chain disruption in 2026 does not come from one place. It comes from five directions at once, and smaller facilities absorb the full force of all five.
1. Tariffs Drive Up Costs on the Supplies You Use Every Day
Surgical gloves manufactured in China now face import tariffs of up to 100% in 2026. Enteral syringes face tariffs as high as 245%. Surgical caps, gowns, instrument components, and exam table paper that originate from China, Mexico, or Canada all carry new cost burdens that did not exist 18 months ago.
For a physician practice or surgery center, this hits differently than it does for a health system. You cannot renegotiate a multi-year GPO contract to absorb the difference. The Medical Group Management Association stated it plainly: physician practices rely on a global supply chain, yet their ability to pass on increased costs is almost nonexistent. A 15% cost increase on PPE and consumables is not an abstraction for a four-room surgery center. It is a real budget crisis that forces choices between margin and quality.
2. Single-Source Manufacturing Creates a Collapse Point
The Baxter International facility in North Cove, North Carolina produced approximately 60% of the country’s IV fluid supply before Hurricane Helene damaged it in late 2024. That one facility disruption forced facilities nationwide to ration normal saline and lactated Ringer’s solution for months. Anesthesia teams substituted fluids that were effective but suboptimal. Surgery schedules shrank.
This is not unique to IV fluids. Carboplatin, a chemotherapy agent used in certain oncology procedures performed in outpatient settings, remains on the ASHP shortage list due to discontinued NDCs (National Drug Codes) and manufacturing delays at a small number of producers. When one NDC gets discontinued and no generic steps in immediately, the entire supply shrinks overnight.
3. Geopolitical Pressure Compounds the Pharmaceutical Problem
China’s retaliatory export controls in 2025 targeted rare-earth metals used in medical imaging contrast agents. Facilities with in-house imaging or diagnostic radiology services saw direct disruption to contrast agent availability. A delayed scan means a delayed diagnosis. A delayed diagnosis means a delayed treatment decision. The supply chain problem does not stop at your loading dock. It walks into your exam room.
Vizient’s 2025 Spend Management Outlook forecast a 2.41% increase in medical supply chain costs for 2026, with pharmaceutical spending projected to grow an additional 3.35%. For a facility operating on thin margins, that trajectory is not sustainable without a proactive sourcing strategy.
Hospital Supply Chain Issues Versus the Non-Acute Reality
The phrase ‘hospital supply chain issues’ dominates industry coverage, but it misses the facilities most at risk. Hospitals have dedicated supply chain officers, centralized purchasing teams, national GPO memberships with volume leverage, and stockroom capacity measured in weeks. Physician offices and surgery centers have none of that.
When a shortage hits a major health system, the procurement team activates alternative vendor protocols, contacts regional distributors, and pulls from central warehouse reserves. When the same shortage hits a 3-room ASC, the office manager calls the distributor rep, hears ‘six-week backorder,’ and starts calling patients.
A 2024 Premier survey of 100 healthcare supply chain leaders found that 39% reported canceling or rescheduling procedures at least quarterly due to product shortages. Surgery and anesthesia supplies topped the shortage categories, affecting 74% of respondents. For an ASC, surgery and anesthesia supplies are not one category among many. They are the entire operation.
Right now, in April and May 2026, ASC partners nationwide reach out for emergency sourcing help for ophthalmology medications and anesthesia-related agents on a near-weekly basis. Carboplatin, propofol, lidocaine injections, and ophthalmic viscoelastic devices appear repeatedly on shortage tracking lists. These are not exotic compounds. They are standard-of-care products that your facility likely uses in every procedure week.
What Drug Shortages Actually Do to Patient Care in Your Office
Nearly 60% of active drug shortages in the United States now last two or more years, according to a 2024 Government Accountability Office analysis. That statistic matters because it changes how you plan. A two-month shortage is a procurement problem. A two-year shortage is a clinical workflow problem.
When your preferred anesthetic agent is unavailable, your anesthesia team substitutes. Substitution sounds simple. It is not. Each substitution requires a prescriber to review the alternative, a pharmacist to verify the dose conversion, nursing staff to monitor for a different adverse effect profile, and documentation to reflect the change. In a high-volume ASC running eight cases a day, that additional workflow per case compounds into hours of staff time and real clinical risk.
A survey by ECRI and the Institute for Safe Medication Practices confirmed that nearly 1 in 2 healthcare workers reported patient treatments had been delayed due to supply chain shortages. In the same data set, nearly 3 in 4 respondents said shortages directly impacted care quality in surgery and anesthesia. Those numbers reflect the full healthcare landscape. In outpatient and non-acute settings, where the margin for delay is even thinner, the real-world impact is sharper.
And the financial damage is real. Drug shortage-related labor costs, alternative sourcing expenses, and canceled procedure revenue add up to roughly $359 million annually across the healthcare system, according to federal ASPE analysis. For an independent surgery center, even a fraction of that proportional burden threatens viability.
Managing Supply Chain Disruptions in a Physician Office or Surgery Center
Managing supply chain disruptions at the practice level does not require a six-figure software platform or a dedicated procurement hire. It requires a clear process, consistent monitoring, and three concrete habits that most facilities do not yet have in place.
Step 1: Know Your Critical Products and Their Risk Profile
Start with your top 20 products by procedure volume. For each one, answer three questions:
- Does this product come from a single manufacturer or a single country of origin?
- Do you have a confirmed secondary source with a known lead time?
- Is this product currently on the FDA shortage list or the ASHP drug shortage database?
If you cannot answer all three questions for your most-used anesthetic agents, injectable antibiotics, ophthalmic solutions, and procedure-specific implants, those products are unmanaged risks. The FDA updates its active shortage database daily. ASHP updates its pharmaceutical shortage list continuously. Both are free and take under 10 minutes to check each week.
Step 2: Run a Supply Chain Gap Assessment for Your Facility
A supply chain gap assessment at the practice level is not a formal audit. It is a structured conversation with your clinical lead, your lead nurse or surgical tech, and whoever manages your ordering. The question is: if your primary distributor called tomorrow with a six-week backorder on your three most critical items, what would you do?
Walk through that scenario product by product. The gaps show up immediately. You will find products where you have no backup vendor contact, items that come from a single overseas manufacturer with no U.S. alternative, and categories where your par levels leave you less than one week of buffer. Each of those is a gap. Write them down. Assign an owner. Set a 30-day deadline to resolve each one.
Step 3: Build Secondary Sourcing Into Your Standard Process
Single-distributor dependence is the most common and most preventable supply chain gap in small and mid-size outpatient facilities. For your 10 highest-risk products, you need a confirmed alternative source with a current account and a known pricing agreement. Not a list of phone numbers. An active account you can place an order with today.
For pharmaceutical products specifically, a secondary specialty pharmacy or a licensed pharmaceutical distributor who specializes in shortage sourcing provides a different supply network than your primary wholesaler. When your primary wholesaler is out, the shortage is often systemic at the wholesaler level. A specialty distributor who sources directly from manufacturers or international licensed suppliers can often find supply that your primary channel cannot.
How Medigroup Sees Supply Chain Resilience for Non-Acute Facilities
At Medigroup, we work directly with physician offices, surgery centers, and specialty practices. We see the supply chain problem from the inside, not from a health system boardroom.
What we observe is a consistent pattern: outpatient facilities build their supply chain around best-case scenarios. They order from one primary distributor, set par levels based on normal demand, and assume the system will work the way it worked last quarter. That approach worked reasonably well before 2020. It does not work in 2026.
Our position is that supply chain resilience for non-acute facilities requires three things that most facilities currently lack: real-time visibility into shortage risk for their specific product mix, at least one active secondary source for every high-volume clinical product, and a clear escalation protocol that clinical and administrative staff can execute without waiting for a manager to make a decision.
None of that is complex. All of it is achievable in 30 days. The difference between a facility that reschedules two patients a quarter and one that reschedules twenty is usually not budget or size. It is preparation.
Three Things Your Facility Can Do This Week
You do not need to wait for a shortage to start building resilience. Here is where to begin:
- Subscribe to FDA MedWatch shortage alerts and ASHP drug shortage notifications. Set a weekly 15-minute review on your calendar. Filter specifically for anesthesia agents, injectable antibiotics, contrast agents, and ophthalmic products. These four categories carry the highest active shortage risk for outpatient surgical facilities right now.
- Contact your primary distributor this week and ask for their current backorder list and projected availability on your top 10 products. Ask specifically: which of these items have had supply interruptions in the last 90 days? The answer will tell you more than any shortage database because it reflects your specific supply network.
- Identify one alternative vendor for your most-used anesthetic and your most-used injectable antibiotic. Open an account. Place one small test order. You want that relationship active before you need it, not on the day you need it.
Supply chain resilience is not a hospital-sized problem that only hospital-sized organizations can solve. It is a patient care issue that every facility owes its patients, regardless of size. The gap between what your supply closet holds and what your next procedure week requires should never be a surprise. With a clear process and the right sourcing relationships in place, it does not have to be.
Whether you’re looking to reduce costs, diversify suppliers, or improve purchasing flexibility, our team can help you build a more resilient supply chain. Reach out to schedule a conversation with our team.
With nearly 25 years of experience, MediGroup leads the industry in focused group purchasing, offering modern cost-saving solutions and expertise to physician practices, surgery centers, and non-acute care facilities. Our passion for contract negotiation provides competitive pricing and flexibility, saving time and money while improving operational efficiency. Join us to optimize your purchasing power and patient care process.
Location: Chesterfield, MO
Areas of expertise: Contract negotiation, cost-saving solutions for medical facilities, building connections between practices, supply chain management.
